<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table5" position="float"><object-id pub-id-type="doi">10.7554/eLife.23708.013</object-id><label>Table 5.</label><caption><title>Multivariable predictors for time to <italic>P. vivax</italic> and <italic>P. falciparum</italic> clinical episodes.</title><p>Model predictions from this model were used for mapping the relative risk of clinical malaria episodes in <xref ref-type="fig" rid="fig3">Figure 3C and D</xref>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Variable</th><th colspan="3"><italic>P. vivax</italic></th><th colspan="3"><italic>P. falciparum</italic></th></tr><tr><th>AHR<sup>*</sup></th><th>CI<sub>95</sub></th><th><italic>p</italic>-value</th><th>AHR<sup>*</sup></th><th>CI<sub>95</sub></th><th><italic>p</italic>-value</th></tr></thead><tbody><tr><td>PQ treatment</td><td>0.76</td><td>0.34&#8211;1.68</td><td>0.497</td><td>1.79</td><td>1.05&#8211;3.03</td><td>0.031</td></tr><tr><td><italic>P. vivax</italic> <sub>mol</sub>FOB<sup>&#8225;</sup></td><td>1.07</td><td>1.04&#8211;1.09</td><td>&lt;0.001</td><td>n.a.</td><td>n.a.</td><td>n.a.</td></tr><tr><td><italic>P. falciparum</italic> <sub>mol</sub>FOB<sup>&#8225;</sup></td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>1.15</td><td>1.11&#8211;1.21</td><td>&lt;0.001</td></tr><tr><td>Age</td><td>0.62</td><td>0.46&#8211;0.84</td><td>0.002</td><td>0.98</td><td>0.85&#8211;1.13</td><td>0. 799</td></tr><tr><td>LLIN use&#160;at enrolment</td><td>0.84</td><td>0.24&#8211;2.88</td><td>0.778</td><td>0.44</td><td>0.22&#8211;0.87</td><td>0.018</td></tr><tr><td>Hb at enrolment (g/dl)</td><td>0.95</td><td>0.74&#8211;0.67</td><td>0.668</td><td>0.85</td><td>0.71&#8211;1.01</td><td>0.070</td></tr><tr><td><italic>Village</italic></td><td/><td/><td/><td/><td/><td/></tr><tr><td>&#8195;Albinama (ref)</td><td>1</td><td/><td/><td>1</td><td/><td/></tr><tr><td>&#8195;Amahup</td><td>0.89</td><td>0.23&#8211;3.46</td><td>0.871</td><td>0.65</td><td>0.20&#8211;2.08</td><td>0.465</td></tr><tr><td>&#8195;Balif</td><td>1.48</td><td>0.45&#8211;4.86</td><td>0.518</td><td>1.26</td><td>0.50&#8211;3.14</td><td>0.626</td></tr><tr><td>&#8195;Balanga</td><td>0.85</td><td>0.21&#8211;3.53</td><td>0.827</td><td>1.39</td><td>0.59&#8211;3.30</td><td>0.455</td></tr><tr><td>&#8195;Bolumita</td><td>0.99</td><td>0.24&#8211;4.03</td><td>0.987</td><td>1.32</td><td>0.58&#8211;3.03</td><td>0.508</td></tr><tr><td>&#8195;Numangu</td><td>1.00</td><td>0.23&#8211;4.31</td><td>0.997</td><td>4.29</td><td>2.06&#8211;8.97</td><td>&lt;0.001</td></tr><tr><td colspan="7"><italic>Infection status at enrolment (by qPCR)</italic></td></tr><tr><td>&#8195;Uninfected (ref)</td><td>1</td><td/><td/><td>1</td><td/><td/></tr><tr><td>&#8195;<italic>P. vivax</italic></td><td>0.77</td><td>0.29&#8211;2.07</td><td>0.608</td><td>1.64</td><td>0.91&#8211;2.95</td><td>0.101</td></tr><tr><td>&#8195;<italic>P. falciparum</italic></td><td>1.74</td><td>0.59&#8211;5.11</td><td>0.316</td><td>0.97</td><td>0.34&#8211;2.77</td><td>0.954</td></tr><tr><td>&#8195;Mixed <italic>P.f. or P.v</italic>.</td><td>1.59</td><td>0.56&#8211;4.50</td><td>0.381</td><td>1.24</td><td>0.57&#8211;2.68</td><td>0.582</td></tr></tbody></table><table-wrap-foot><fn><p>* AHRs were modeled using multiple failure Cox proportional hazard regression.</p><p>&#8224; n.a., not applicable</p></fn><fn><p>&#8225; Average <sub>mol</sub>FOB until the time of failure (time-varying covariate).</p><p>PQ: Primaquine; LLIN: long-lasting insecticide-treated net; Hb: haemoglobin.</p></fn></table-wrap-foot></table-wrap>